These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epithelial ovarian carcinoma and European birthplace of grandparents. Harlap S; Olson S; Akhmedkhanov A; Barakat RR; Caputo T; Sanchez D; Xue X Gynecol Oncol; 2001 Apr; 81(1):25-32. PubMed ID: 11277645 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic x-rays and risk of epithelial ovarian carcinoma in Jews. Harlap S; Olson SH; Barakat RR; Caputo TA; Forment S; Jacobs AJ; Nakraseive C; Xue X Ann Epidemiol; 2002 Aug; 12(6):426-34. PubMed ID: 12160602 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for epithelial ovarian cancer in Beijing, China. Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for epithelial ovarian tumours of borderline malignancy. Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425 [TBL] [Abstract][Full Text] [Related]
6. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589 [TBL] [Abstract][Full Text] [Related]
7. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563 [TBL] [Abstract][Full Text] [Related]
10. Gender of offspring and maternal risk of invasive epithelial ovarian cancer. Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920 [TBL] [Abstract][Full Text] [Related]
11. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Kurta ML; Moysich KB; Weissfeld JL; Youk AO; Bunker CH; Edwards RP; Modugno F; Ness RB; Diergaarde B Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1282-92. PubMed ID: 22707710 [TBL] [Abstract][Full Text] [Related]
12. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Risch HA; Marrett LD; Howe GR Am J Epidemiol; 1994 Oct; 140(7):585-97. PubMed ID: 7942759 [TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532 [TBL] [Abstract][Full Text] [Related]
14. Anthropometry and the risk of epithelial ovarian cancer. Greer JB; Modugno F; Ness RB; Allen GO Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653 [TBL] [Abstract][Full Text] [Related]
15. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107 [TBL] [Abstract][Full Text] [Related]
17. Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. Rutter JL; Wacholder S; Chetrit A; Lubin F; Menczer J; Ebbers S; Tucker MA; Struewing JP; Hartge P J Natl Cancer Inst; 2003 Jul; 95(14):1072-8. PubMed ID: 12865453 [TBL] [Abstract][Full Text] [Related]
18. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Ness RB; Cramer DW; Goodman MT; Kjaer SK; Mallin K; Mosgaard BJ; Purdie DM; Risch HA; Vergona R; Wu AH Am J Epidemiol; 2002 Feb; 155(3):217-24. PubMed ID: 11821246 [TBL] [Abstract][Full Text] [Related]
19. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. Modan B; Hartge P; Hirsh-Yechezkel G; Chetrit A; Lubin F; Beller U; Ben-Baruch G; Fishman A; Menczer J; Struewing JP; Tucker MA; Wacholder S; N Engl J Med; 2001 Jul; 345(4):235-40. PubMed ID: 11474660 [TBL] [Abstract][Full Text] [Related]